Bicocca Open Archive

Logo unimib boa
FAVERIO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.952
AS - Asia 8.686
EU - Europa 6.428
SA - Sud America 1.412
AF - Africa 236
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 2
Totale 29.745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.595
SG - Singapore 3.040
CN - Cina 1.635
IT - Italia 1.577
VN - Vietnam 1.464
BR - Brasile 1.057
DE - Germania 1.039
HK - Hong Kong 1.029
RU - Federazione Russa 1.019
SE - Svezia 671
IE - Irlanda 503
GB - Regno Unito 392
IN - India 296
FR - Francia 287
ID - Indonesia 219
FI - Finlandia 193
CA - Canada 192
BD - Bangladesh 155
UA - Ucraina 126
AR - Argentina 119
JP - Giappone 117
AT - Austria 109
TR - Turchia 103
MX - Messico 101
ES - Italia 97
KR - Corea 97
IQ - Iraq 93
NL - Olanda 87
ZA - Sudafrica 86
PK - Pakistan 75
SA - Arabia Saudita 65
PL - Polonia 61
CH - Svizzera 58
CO - Colombia 57
PH - Filippine 49
EC - Ecuador 46
DK - Danimarca 41
BE - Belgio 40
UZ - Uzbekistan 38
MA - Marocco 32
CZ - Repubblica Ceca 30
PY - Paraguay 29
CL - Cile 26
AU - Australia 25
VE - Venezuela 25
KE - Kenya 24
AE - Emirati Arabi Uniti 23
MY - Malesia 23
PE - Perù 23
EG - Egitto 21
TN - Tunisia 19
JO - Giordania 18
LT - Lituania 17
PT - Portogallo 15
BO - Bolivia 14
TH - Thailandia 14
ET - Etiopia 13
IL - Israele 13
JM - Giamaica 13
UY - Uruguay 12
IR - Iran 11
KZ - Kazakistan 11
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
LB - Libano 10
DZ - Algeria 9
PS - Palestinian Territory 9
RO - Romania 9
TW - Taiwan 9
AL - Albania 8
KG - Kirghizistan 8
MN - Mongolia 8
NP - Nepal 8
SN - Senegal 8
BG - Bulgaria 7
PA - Panama 7
CR - Costa Rica 6
HN - Honduras 6
HU - Ungheria 6
OM - Oman 6
TT - Trinidad e Tobago 6
BY - Bielorussia 5
EE - Estonia 5
LK - Sri Lanka 5
RS - Serbia 5
BB - Barbados 4
GR - Grecia 4
HR - Croazia 4
NZ - Nuova Zelanda 4
SC - Seychelles 4
SV - El Salvador 4
UG - Uganda 4
BH - Bahrain 3
CY - Cipro 3
GE - Georgia 3
KH - Cambogia 3
MD - Moldavia 3
MM - Myanmar 3
NI - Nicaragua 3
SR - Suriname 3
Totale 29.701
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.176
Singapore 1.855
Ashburn 1.276
San Jose 1.019
Hong Kong 1.011
Fairfield 687
Chandler 678
Frankfurt am Main 645
Dublin 482
Milan 456
Ho Chi Minh City 447
Wilmington 423
New York 380
Houston 369
Hanoi 336
Santa Clara 336
Woodbridge 307
Dallas 299
Chicago 275
Los Angeles 274
Seattle 272
Beijing 253
Cambridge 203
Hefei 187
Jakarta 173
Princeton 172
The Dalles 158
Dearborn 155
Council Bluffs 130
São Paulo 129
Helsinki 118
Shanghai 118
Lauterbourg 112
Munich 110
Buffalo 107
Moscow 86
Altamura 85
Jacksonville 84
Seoul 83
London 82
Lawrence 81
Nanjing 80
Orem 74
Vienna 74
Tokyo 72
Rome 67
Boardman 61
Fremont 59
Guangzhou 58
Haiphong 53
Da Nang 52
Zurich 51
Atlanta 48
Montreal 48
San Diego 48
Nuremberg 47
Warsaw 47
Toronto 46
Johannesburg 45
Rio de Janeiro 45
Chennai 39
Stockholm 38
Denver 37
Brooklyn 35
Brussels 35
Dhaka 35
Dong Ket 35
Turku 34
Mexico City 33
Monza 33
Tashkent 33
Lappeenranta 31
Biên Hòa 30
Columbus 29
Phoenix 29
Poplar 29
Amsterdam 28
Baghdad 28
Brasília 28
Jinan 28
Hangzhou 26
Manchester 26
Ankara 25
Bắc Ninh 25
Riyadh 25
Salt Lake City 25
Belo Horizonte 24
Boston 24
Lissone 24
New Delhi 24
Andover 23
Bogotá 23
Ha Long 23
Nanchang 23
Paris 23
Turin 23
Düsseldorf 21
Hải Dương 21
Kent 21
Mumbai 21
Totale 18.821
Salva come PNG Salva come JPEG
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 516
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 497
The ‘Liaisons dangereuses’ Between Lung Cancer and Interstitial Lung Diseases: A Focus on Acute Exacerbation 487
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 467
Diagnostic delay in bronchiectasis: an Italian perspective 434
Progressive fibrosing interstitial lung diseases: prevalence and characterization in two Italian referral centers 425
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 420
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 416
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 405
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study 388
Early referral to palliative care services in patients with IPF: A tool to take a step forward 385
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 383
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 364
A second update on mapping the human genetic architecture of COVID-19 361
Rehospitalization for pneumonia after first pneumonia admission: Incidence and predictors in a population-based cohort study 346
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 346
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 343
Mapping the human genetic architecture of COVID-19 334
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 331
Prolonged exposure to welding fumes as a novel cause of systemic iron overload 330
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 326
Idiopathic pulmonary fibrosis mortality in the Italian epicenter of COVID-19 pandemic 322
Corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A single center experience and literature review 320
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 318
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 307
Management of acute respiratory failure in interstitial lung diseases: Overview and clinical insights 306
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 297
Impact of traffic-related air pollution on pulmonary oxidative stress 294
Clinical Characteristics of Anti-synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 293
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study 289
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 288
Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy 285
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 285
Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study 284
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 283
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: A multinational point prevalence study of hospitalised patients 280
Janus-faced amiodarone-induced pneumopathy 280
Influenza A/H1N1 severe pneumonia: Novel morphocytological findings in bronchoalveolar lavage 279
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 278
Allergic bronchopulmonary aspergillosis screening in bronchiectasis: Is there always a precise answer to a clear question? 277
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 276
Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study 269
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 268
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 266
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 266
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia 263
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases 261
A multidisciplinary approach to screen the post-COVID-19 conditions 260
A 61-year-old female with chronic cough and purulent sputum 258
Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study 258
Phenotyping in Bronchiectasis: Are we moving towards a personalized medicine? 250
Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis 240
Therapeutic Management of Bronchiectasis in Children and Adolescents: A Concise Narrative Review 238
History of lung volume reduction procedures 238
The management of community-acquired pneumonia in the elderly 235
Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study 235
Molecular biomarkers in idiopathic pulmonary fibrosis: State of the art and future directions 235
Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians 233
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 230
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 229
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD 227
Hospital admission decision for patients with community-acquired pneumonia 227
Individualizing duration of antibiotic therapy in community-acquired pneumonia 225
Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study 224
EBUS-TBNA nella patologia mediastino-polmonare: analisi retrospettiva dei primi 3 anni di attività di un singolo centro 223
Impact of N-acetyl-L-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study 223
Systemic sclerosis and outcome in intensive care unit: Do not close the door, open the right protocol 217
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia 215
Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis 210
Long-term prognosis in community-acquired pneumonia 208
Clinical differences in sarcoidosis patients with and without lymphoma: A single-centre retrospective cohort analysis 208
Feasibility and clinical impact of a portable bi-level ventilation device in patients with severe chronic obstructive pulmonary disease and exertional dyspnea: preliminary results from a clinical series 208
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 207
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach 203
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 202
Evaluation of preoperative cardiopulmonary reserve and surgical risk of patients undergoing lung cancer resection 201
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 200
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 200
Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population 199
Obstructive sleep apnea is associated with higher healthcare utilization in elderly patients 199
Idiopathic interstitial pneumonia in a patient with von Hippel-Lindau syndrome: a first case 197
Questionnaires May Help Pulmonologists for Referral of Patients With IPF to a Holistic Approach 193
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 189
Long-term macrolides in diffuse interstitial lung diseases 189
Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan 189
Alteration of Lipid Metabolism in Patients with IPF and Its Association with Disease Severity and Prognosis: A Case–Control Study 184
Cystic lung in sarcoidosis: Clinico-radiologic characteristic and evolution 181
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers 180
Multidisciplinary approach to systemic diseases: benefits for diagnosis and management of complex disorders 178
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 177
Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update 176
Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumonia 175
Clinical Impact of Vaping 174
Prevention of ventilator-associated pneumonia in the intensive care unit: a review of the clinically relevant recent advancements 171
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres 170
Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function 169
Interstitial pneumonia associated with autoimmune diseases: a possible mimicker of SARS-CoV-2 pneumonia 169
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases 167
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients 167
Non-antibiotic therapies for CAP 165
Totale 26.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.345
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 0 0 0 0 0 172 208
2021/20221.818 192 193 230 174 100 159 75 122 74 98 134 267
2022/20232.658 278 694 307 232 191 386 44 185 170 27 82 62
2023/20241.960 54 74 123 100 239 452 339 96 121 52 39 271
2024/20255.505 300 557 293 261 431 334 375 234 564 888 510 758
2025/202612.732 1.882 827 998 1.575 1.572 722 2.010 659 1.168 1.141 178 0
Totale 30.421